HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Douglas D Ross Selected Research

carboxycinnamic acid bishydroxamide

12/2005Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Douglas D Ross Research Topics

Disease

27Breast Neoplasms (Breast Cancer)
01/2016 - 01/2003
22Neoplasms (Cancer)
03/2015 - 11/2002
7Leukemia
04/2013 - 01/2003
5Prostatic Neoplasms (Prostate Cancer)
02/2021 - 07/2005
4Hypoxia (Hypoxemia)
04/2012 - 06/2004
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2013 - 08/2003
3Choriocarcinoma
03/2008 - 12/2004
2Carcinoma (Carcinomatosis)
03/2015 - 08/2010
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2013 - 03/2009
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2016
1Fatigue
04/2013
1Hyperbilirubinemia
04/2013
1Anorexia
04/2013
1Ovarian Neoplasms (Ovarian Cancer)
09/2010
1Blast Crisis (Blast Phase)
03/2009
1Myeloid Leukemia (Leukemia, Myelocytic)
03/2009
1Sudden Death
12/2005

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
10/2016 - 01/2003
10Pharmaceutical PreparationsIBA
02/2012 - 11/2002
8Adenosine Triphosphate (ATP)IBA
04/2012 - 06/2003
6ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2016 - 10/2003
6Mitoxantrone (Novantrone)FDA LinkGeneric
02/2008 - 01/2004
4Messenger RNA (mRNA)IBA
03/2015 - 08/2003
4Cytarabine (Cytosar-U)FDA LinkGeneric
04/2013 - 03/2005
4Histone Deacetylase InhibitorsIBA
04/2013 - 07/2005
4VorinostatFDA Link
04/2013 - 12/2005
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2010 - 01/2003
4alvocidib (flavopiridol)IBA
08/2007 - 01/2003
4Topotecan (Hycamtin)FDA LinkGeneric
09/2006 - 01/2004
3AndrogensIBA
02/2021 - 08/2007
3Imatinib Mesylate (Gleevec)FDA Link
06/2013 - 07/2006
3Etoposide (VP 16)FDA LinkGeneric
04/2013 - 03/2005
2Androgen Receptors (Androgen Receptor)IBA
02/2021 - 07/2005
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
12/2010 - 08/2010
2LigandsIBA
08/2010 - 06/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2009 - 12/2005
2Drug CombinationsIBA
03/2009 - 07/2008
2Hormones (Hormone)IBA
03/2008 - 07/2005
2theasinensin AIBA
12/2005 - 07/2005
2Irinotecan (Camptosar)FDA LinkGeneric
02/2004 - 01/2004
2Anti-Bacterial Agents (Antibiotics)IBA
01/2004 - 08/2003
1enzalutamideIBA
02/2021
1abirateroneIBA
02/2021
1Metformin (Glucophage)FDA LinkGeneric
02/2021
1CCAAT-Enhancer-Binding ProteinsIBA
10/2016
1Cyclic AMP (AMP, Cyclic)IBA
03/2015
1ErbB Receptors (EGF Receptor)IBA
03/2015
1Dasatinib (BMS 354825)FDA Link
06/2013
1ProlactinIBA
02/2013
1XenobioticsIBA
04/2012
1Heme (Haem)IBA
04/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
04/2012
1Histones (Histone)IBA
02/2012
1Estrogen ReceptorsIBA
02/2012
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2012
1BMS 536924IBA
01/2011
1benzimidazoleIBA
01/2011
1Insulin-Like PeptidesIBA
01/2011
1Insulin ReceptorIBA
01/2011
1Somatomedin Receptors (Somatomedin Receptor)IBA
01/2011
1MethylcholanthreneIBA
12/2010
1Rosiglitazone (Avandia)FDA Link
12/2010
1Omeprazole (Prilosec)FDA LinkGeneric
12/2010
1TOR Serine-Threonine KinasesIBA
09/2010
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
09/2010
1AminopeptidasesIBA
09/2010
1Amino AcidsFDA Link
09/2010
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2009
1Tissue Inhibitor of Metalloproteinase-1IBA
06/2009
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
06/2009
1von Willebrand FactorIBA
06/2009
1Tissue Inhibitor of Metalloproteinase-2IBA
06/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2009
1Interleukin-6 (Interleukin 6)IBA
06/2009
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2009
1NF-kappa B (NF-kB)IBA
06/2009
1Cyclin D1IBA
06/2009
1Interleukin-8 (Interleukin 8)IBA
06/2009
1Propidium (Propidium Iodide)IBA
03/2009
1SaltsIBA
03/2009
1diacetylfluorescein (fluorescein diacetate)IBA
03/2009
1Antiviral Agents (Antivirals)IBA
07/2008
1Progesterone Receptors (Progesterone Receptor)IBA
03/2008
1Protein Isoforms (Isoforms)IBA
03/2008
1ProgesteroneFDA LinkGeneric
03/2008
1SteroidsIBA
03/2008
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
02/2008
1Docetaxel (Taxotere)FDA Link
02/2008
1Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA
02/2008
1ThapsigarginIBA
08/2007
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
08/2007
1Sirolimus (Rapamycin)FDA Link
09/2006
1Tacrolimus (Prograf)FDA LinkGeneric
09/2006
1Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2006
1Tyrosine Kinase InhibitorsIBA
07/2006
15' Untranslated Regions (5' UTR)IBA
05/2006
1carboxycinnamic acid bishydroxamideIBA
12/2005
1Histone Deacetylases (Histone Deacetylase)IBA
12/2005

Therapy/Procedure

9Therapeutics
06/2013 - 01/2003
3Drug Therapy (Chemotherapy)
12/2004 - 08/2004